MetrioPharm AG
PrivateLast Round
VC Round
Oct 1, 2023
Est. Valuation
$163.04M
Total Funding Raised
$59.64M
Company Overview
MetrioPharm AG is a clinical-stage biopharmaceutical company that develops first-in-class, self-regulating immunomodulators for the treatment of inflammatory and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MetrioPharm AG Comparables
Compare MetrioPharm AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InflaRx N.V. | 74% | |
| Kymera Therapeutics, Inc. | 71% | |
| OMEICOS Therapeutics | 69% |
MetrioPharm AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 1, 2023 | ||||
| Grant | Oct 12, 2022 | ||||
| VC Round | Oct 1, 2022 | ||||
| Grant | Nov 1, 2021 | ||||
| Series E | Oct 12, 2021 | ||||
Series D | Dec 11, 2018 |
MetrioPharm AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Duchenne UK | Grant |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors grew 79% MoM, from 616 to 1.1K.
- Sep 12, 2025
Professor Dr. Marcus Thelen appointed as Chief Scientific Officer.
MetrioPharm AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MetrioPharm AG's valuation, stock price, and market status.
Is MetrioPharm AG a public or private company?
MetrioPharm AG is a private company.
What is the current stock price of MetrioPharm AG?
MetrioPharm AG is a private company with no public stock price. No recent secondary market data is available.
How much is MetrioPharm AG worth (valuation)?
MetrioPharm AG's valuation is estimated at $163.0M based on funding round data.
Can I buy MetrioPharm AG stock?
MetrioPharm AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MetrioPharm AG's last funding round?
MetrioPharm AG's most recent funding round was VC Round on October 1, 2023.
Who are the main investors in MetrioPharm AG?
Key investors in MetrioPharm AG include Duchenne UK, European Union.
Will MetrioPharm AG IPO soon?
No public IPO plans have been announced for MetrioPharm AG.
How can I track MetrioPharm AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MetrioPharm AG's secondary market activity and sign up for updates.